TY  - JOUR
AU  - Lebret, T
AU  - Casas, A
AU  - Cavo, M
AU  - Woll, P J
AU  - Deleplace, C
AU  - Kennedy, C
AU  - Schoen, P
AU  - Jackisch, C
PY  - 2016
DO  - 10.1111/ecc.12490
UR  - http://hdl.handle.net/10668/9992
T2  - European journal of cancer care
AB  - Bone metastases in patients with solid tumours (ST) and bone lesions in patients with haematological malignancies (HM) are common. Associated skeletal-related events (SREs) cause severe pain, reduced quality of life and place a burden on health care...
LA  - en
KW  - bisphosphonate
KW  - bone metastases
KW  - bone-targeted agent
KW  - haematological malignancy
KW  - skeletal-related event
KW  - solid tumour
KW  - Aged
KW  - Bone Density Conservation Agents
KW  - Bone Neoplasms
KW  - Diphosphonates
KW  - Europe
KW  - Female
KW  - Hematologic Neoplasms
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Neoplasms
KW  - Patient Safety
KW  - Time-to-Treatment
KW  - Treatment Outcome
TI  - The use of bisphosphonates in the management of bone involvement from solid tumours and haematological malignancies - a European survey.
TY  - research article
VL  - 26
ER  -